Sign in

You're signed outSign in or to get full access.

Joanne T. Medero

About Joanne T. Medero

Independent director with 30+ years in financial services, specializing in government relations, derivatives regulation, and fund governance; joined the Nuveen Funds Board in 2021 and serves across the Fund Complex including NUV (Nuveen Municipal Value Fund, Inc.). Education: B.A., St. Lawrence University (1975); J.D., George Washington University Law School (1978). She is classified as an Independent Board Member (not an “interested person” under the 1940 Act; no employment history with TIAA or Nuveen).

Past Roles

OrganizationRoleTenureCommittees/Impact
BlackRock, Inc.Managing Director, Government Relations & Public Policy; Senior Advisor to Vice ChairmanMD: Dec 2009–Jul 2020; Senior Advisor: Jul 2018–Jul 2020Led public policy and corporate governance engagement for a leading asset manager.
Barclays Global Investors (BGI)Managing Director; Global General Counsel & Corporate Secretary1996–2006Oversaw global legal and corporate secretarial functions for a major investment manager.
Barclays Group (IBIM)Managing Director; Global Head of Government Relations & Public Policy2006–2009Directed legislative/regulatory advocacy for investment banking, investment management, and wealth businesses.
Orrick, Herrington & Sutcliffe LLPPartner (Derivatives & Financial Markets Regulation)1993–1995Specialized counsel on derivatives regulatory issues.
Commodity Futures Trading Commission (CFTC)General Counsel1989–1993Chief legal officer; significant regulatory leadership in U.S. derivatives markets.
The White House, Office of Presidential PersonnelDeputy Associate Director/Associate Director (Legal & Financial Affairs)1986–1989Public service role shaping personnel policy in legal/financial areas.
Managed Funds AssociationChair, CTA/CPO & Futures Committee2010–2012Industry leadership in derivatives/futures policy.
SIFMA Asset Management GroupChair, Steering Committee2016–2018Led asset management industry governance/policy initiatives.
CFTC Global Markets Advisory CommitteeMember2006–2010Advised on global markets issues.
The Federalist SocietyChair, Corporations, Antitrust & Securities Practice Group2010–2022; and 2000–2002Led legal practice group discussions/standards.

External Roles

OrganizationRoleTenureNotes
Baltic-American Freedom FoundationDirectorSince 2019Non-profit focus on Baltic-U.S. exchange programs.
SIFMA Asset Management GroupSteering Committee Chair2016–2018Industry governance and policy engagement.
Managed Funds AssociationCommittee Chair (CTA/CPO & Futures)2010–2012Derivatives industry policy leadership.
The Federalist SocietyPractice Group Chair2010–2022; 2000–2002Corporate/securities law community leadership.

Board Governance

  • Independence: Classified as an Independent Board Member; not an “interested person” of the Funds or Adviser; no employment history with TIAA or Nuveen.
  • Committee memberships (2025):
    • Nominating & Governance Committee (member; Chair: Robert L. Young).
    • Investment Committee (member; Co-Chairs: Joseph A. Boateng and Amy B.R. Lancellotta).
    • Compliance, Risk Management & Regulatory Oversight Committee (member; Chair: Margaret L. Wolff).
    • Not listed on Audit Committee, Executive Committee, Dividend Committee, or Closed-End Fund Committee.
  • Attendance: Each Board Member attended at least 75% of the Board and applicable committee meetings during the last fiscal year.
  • Tenure and term classification: Joined the Funds’ Board in 2021; for Municipal Value (NUV), designated a Class III Board Member with current term expiring at the 2027 annual meeting.
  • Board leadership context: Independent Chair of the Board is Robert L. Young (Chair since 2025).

Fixed Compensation

ComponentAmountNotes
Annual retainer (Independent Board Members)$350,000Effective Jan 1, 2025.
Committee membership retainersAudit: $35,000; Compliance: $35,000; Investment: $30,000; Dividend: $25,000; Nominating & Governance: $25,000; Closed-End Funds: $25,000Effective Jan 1, 2025; applies per committee membership.
Committee chair retainersAudit: $35,000; Compliance: $35,000; Investment Chair/Co-Chair: $30,000; Dividend/Nominating/Closed-End: $25,000Effective Jan 1, 2025; Medero is not a chair.
Board Chair retainer$150,000Independent Chair only (Young).
Ad hoc meeting fees$1,000–$2,500 per meetingBased on length/immediacy.
Special assignment committee feesChair/Co-Chair: starting $1,250/quarter; Members: starting $5,000/quarterAs applicable.
Deferred Compensation PlanAvailable to Independent Board Members; account tracked to Nuveen funds’ shares; lump sum or 2–20 year distribution optionsPlan mechanics and fund obligations described.
Aggregate compensation from NUV (Municipal Value)$5,304Fiscal year ended Oct 31, 2024.
Total compensation across Nuveen Funds (Fund Complex)$461,987Aggregate paid to Medero from Nuveen Funds.

Compensation structure shifted from per-meeting fees (2023) to higher fixed retainers (2024/2025), increasing cash predictability and reducing meeting-based variability.

Performance Compensation

  • No performance-based metrics or bonuses disclosed for Independent Board Members; compensation consists of fixed retainer and committee retainers, with optional deferred compensation elections.

Other Directorships & Interlocks

CategoryDisclosure
Public company boards (current/past 5 years)None disclosed for Medero in the NUV proxy biography.
Non-profit/academic boardsBaltic-American Freedom Foundation (Director since 2019).
Industry associationsSIFMA AMG Steering Committee Chair (2016–2018); MFA committee chair (2010–2012); Federalist Society practice group chair (2010–2022; 2000–2002).
Interlocks with competitors/suppliers/customersNot disclosed; Board Members are independent of TIAA/Nuveen and not “interested persons.”

Expertise & Qualifications

  • Regulatory/legal expertise: Former CFTC General Counsel; partner in derivatives regulation; extensive government relations leadership at BlackRock and Barclays—strong oversight and compliance skill set for fund boards.
  • Industry governance experience: Leadership roles in SIFMA, MFA, and Federalist Society practice group; active in policy-shaping forums relevant to asset management.
  • Education: B.A. (1975) and J.D. (1978).

Equity Ownership

ItemDetail
Ownership guidelineEach Board Member is expected to invest at least the equivalent of one year of compensation in funds within the Fund Complex (directly or deferred).
Beneficial ownership %Each Board Member’s individual beneficial shareholdings in each Fund were less than 1% of outstanding shares as of June 20, 2025.
Deferred fees payable (NUV)$1,908 attributable to Medero under the Deferred Compensation Plan (Fund: Municipal Value; fiscal year reference per table).

Section 16(a) compliance: The Funds report that Board Members and officers complied with all applicable filing requirements during the last fiscal year.

Governance Assessment

  • Strengths: Independent status; multi-committee engagement across Nominating & Governance, Investment, and Compliance—aligns with governance and risk oversight focus.
  • Attendance and engagement: Met the 75%+ attendance threshold across Board and committee meetings, supporting active oversight.
  • Expertise fit: Deep regulatory/legal background (CFTC, derivatives, government relations) enhances board effectiveness in compliance and policy-sensitive areas.
  • Alignment mechanisms: Board guideline to invest one year of compensation in Fund Complex; optional deferrals tied to Nuveen fund share values support shareholder alignment.
  • Compensation structure signals: Transition to higher fixed retainers (from meeting fees) standardizes pay and may improve consistency of engagement; no performance-based director pay disclosed, reducing potential misaligned incentives.
  • Potential conflicts: Prior senior roles at BlackRock/Barclays are industry-relevant but the proxy affirms independence from TIAA/Nuveen; no related-party transactions or cross-ownership disclosures involving Medero flagged.
  • Red flags: None identified—no delinquent Section 16 reports; no pledging/hedging or related-party transactions disclosed for Medero; not on Audit Committee (neutral—Audit depth covered by other designated financial experts).

Overall, Medero’s regulatory and governance credentials, independent status, and multi-committee participation support investor confidence in Board oversight at NUV, with low interlock/conflict risk based on current disclosures.